We are live on ! Find out more
SBH

Segall Bryant & Hamill Portfolio holdings

AUM $6.98B
1-Year Est. Return 34.78%
This Fund
S&P 500
This Quarter Est. Return
+10.64%
1 Year Est. Return
+34.78%
3 Year Est. Return
+85.12%
5 Year Est. Return
+106.02%
10 Year Est. Return
+446.97%
AUM
$7.33B
AUM Growth
+$1.69B
Cap. Flow
+$1.15B
Cap. Flow %
15.72%
Top 10 Hldgs %
11.92%
Holding
611
New
202
Increased
183
Reduced
174
Closed
49

Top Sells

Rank Stock Value
1
DT icon
Dynatrace
DT
+$106M
2
SPXC icon
SPX Corp
SPXC
+$28.8M
3
EQC
Equity Commonwealth
EQC
+$25.2M
4
GIL icon
Gildan
GIL
+$24.7M
5
ICUI icon
ICU Medical
ICUI
+$17.3M

Sector Composition

Rank Sector Weight
1 Industrials 19.48%
2 Technology 18.29%
3 Financials 14.4%
4 Healthcare 13.59%
5 Consumer Discretionary 10.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ORRF icon
351
Orrstown Financial Services
ORRF
$851M
$4.48M 0.06%
124,652
+2,143
+2% +$71K
SWTX
352
DELISTED
SpringWorks Therapeutics
SWTX
$4.32M 0.06%
134,937
-5,504
-4% -$206K
JJSF icon
353
J&J Snack Foods
JJSF
$1.54B
$4.3M 0.06%
24,960
+1,324
+6% +$222K
NBIX icon
354
Neurocrine Biosciences
NBIX
$16.6B
$4.2M 0.06%
36,472
-512
-1% -$70.2K
VSTS icon
355
Vestis
VSTS
$1.86B
$4.19M 0.06%
281,131
-11,431
-4% -$153K
AUPH icon
356
Aurinia Pharmaceuticals
AUPH
$1.95B
$4.13M 0.06%
562,775
+9,031
+2% +$56K
ASC icon
357
Ardmore Shipping
ASC
$684M
$4.09M 0.06%
225,995
-29,237
-11% -$564K
AMRX icon
358
Amneal Pharmaceuticals
AMRX
$5.97B
$4.07M 0.06%
489,162
+7,661
+2% +$59.9K
MLR icon
359
Miller Industries
MLR
$581M
$4.07M 0.06%
66,672
+990
+2% +$59.5K
NEE icon
360
NextEra Energy
NEE
$179B
$4.05M 0.06%
+47,967
New +$3.74M
PAHC icon
361
Phibro Animal Health
PAHC
$1.45B
$3.93M 0.05%
174,569
+2,971
+2% +$57.4K
LW icon
362
Lamb Weston
LW
$7.32B
$3.9M 0.05%
60,267
-17,523
-23% -$1.16M
PTVE
363
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$3.9M 0.05%
+338,776
New +$3.89M
PENG
364
Penguin Solutions Inc
PENG
$2.92B
$3.86M 0.05%
184,356
-87,124
-32% -$1.88M
CYTK icon
365
Cytokinetics
CYTK
$10.7B
$3.83M 0.05%
72,451
-2,947
-4% -$164K
PM icon
366
Philip Morris
PM
$292B
$3.78M 0.05%
+31,160
New +$3.62M
VO icon
367
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$3.77M 0.05%
+57,220
New +$3.59M
MIR icon
368
Mirion Technologies
MIR
$3.94B
$3.76M 0.05%
339,674
-13,872
-4% -$146K
TBCH
369
Turtle Beach Corp
TBCH
$270M
$3.72M 0.05%
242,735
+3,620
+2% +$52.8K
BNL icon
370
Broadstone Net Lease
BNL
$4.07B
$3.69M 0.05%
+194,766
New +$3.44M
FIVN icon
371
FIVE9
FIVN
$2.27B
$3.69M 0.05%
128,417
-54,298
-30% -$1.96M
AMKR icon
372
Amkor Technology
AMKR
$13.8B
$3.68M 0.05%
120,258
-42,595
-26% -$1.45M
METC icon
373
Ramaco Resources Class A
METC
$611M
$3.64M 0.05%
321,124
+4,610
+1% +$55K
HSTM icon
374
HealthStream
HSTM
$835M
$3.61M 0.05%
125,164
+2,020
+2% +$57.9K
TXN icon
375
Texas Instruments
TXN
$255B
$3.56M 0.05%
+17,214
New +$3.46M

Similar funds

Segall Bryant & Hamill's Q3 2024 Portfolio in Review

As of Q3 2024, Segall Bryant & Hamill held 611 positions worth $7.33B, up 30% from $5.64B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Segall Bryant & Hamill deployed $1.15B of net new capital in Q3 2024, opening 202 new positions and adding to 183 existing holdings. Its largest new stake was NVIDIA: 687,551 shares worth $83.5M.

By sector, the portfolio is most concentrated in Industrials at 19% of assets, down from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SPX Corp, an estimated $28.8M trimmed.

  • Segall Bryant & Hamill's largest Q3 2024 buy was NVIDIA: 687,551 shares worth $83.5M.
  • Segall Bryant & Hamill added most to Microsoft in Q3 2024, an estimated $91.1M increase.
  • Segall Bryant & Hamill's biggest Q3 2024 reduction was SPX Corp, cutting an estimated $28.8M.
  • Segall Bryant & Hamill fully exited Dynatrace in Q3 2024, selling an estimated $106M.
  • Segall Bryant & Hamill's ten largest holdings make up 12% of its $7.33B portfolio in Q3 2024.
  • Segall Bryant & Hamill opened 202 new positions and closed 49 in Q3 2024.
  • Segall Bryant & Hamill's portfolio value rose 30% quarter-over-quarter to $7.33B.

Based on Segall Bryant & Hamill's 13F filing for Q3 2024, filed 8 Nov 2024.